KARAMOUZIS, IOANNIS
KARAMOUZIS, IOANNIS
SCIENZE MEDICHE
*ASSESSMENT OF BONE BIOCHEMICAL INDICATORS IN THALASSAEMIA AND SICKLE CELL ANEMIA*
2010-01-01 *K.Thisiadou;I.Karamouzis;S.Arampatzi;M.Karamouzis.*
*Calcium-phosphorus metabolism and parathyroid function in patients with end stage chronic kidney disease*
2010-01-01 *I.Karamouzis ;K.Thisiadou;S.Arampatzi;D.Michailidou*
EFFECT OF PROLONGED TREATMENT WITH POTASSIUM CANRENOATE, A MR ANTAGONIST, ON BASAL AND STIMULATED HYPOTHALAMUS-PITUITARY-ADRENAL (HPA) AXIS IN HUMANS
2009-01-01 R. Berardelli; E. Marinazzo; E. Prats; A. Picu; R. Giordano; I. Karamouzis; E. Ghigo; E Arvat
GLUCOCORTICOID RECEPTOR POLYMORPHISMS AND METABOLIC-CARDIOVASCULAR PROFILE IN PATIENTS WITH ADDISON’S DISEASE UNDER REPLACEMENT THERAPY
2011-01-01 R. Giordano; S. Marzotti; R. Berardelli; I. Karamouzis; E. Marinazzo; A. Picu; D. Forno; D. Zinnà; D. Giachino; A. Falorni; E. Ghigo; E. Arvat
METABOLIC AND CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT ETIOLOGY BEFORE AND 1 YEAR AFTER DISEASE REMISSION
2010-01-01 A. Picu; E. Marinazzo; M. Balbo; R. Berardelli; I. Karamouzis; E. Ghigo; R. Giordano; E. Arvat
THE INHIBITORY EFFECT OF FLUDROCORTISONE ON HPA AXIS IS NOT ONLY EXERTED THROUGH HIPPOCAMPAL MR RECEPTORS: POSSIBLE CLINICAL IMPLICATIONS
2010-01-01 R. Berardelli; I. Karamouzis; E. Marinazzo; A. Picu; R. Giordano; E. Ghigo; E. Arvat